Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

The $200 Popcorn Popper That Keeps Selling Out

October 1, 2026

Challenged Athletes Foundation Receives Rings of Gold Award from U.S. Olympic & Paralympic Committee

October 1, 2026

CleanChoice Energy Closes Approximately $166M in Project Financing and Tax Equity for Two Solar Projects

October 1, 2026

Fabletics Launches Fabletics Reserve Credit Card, Expanding Value and Loyalty Perks to Its More than 2.7 Million Members

October 1, 2026

First Merchants Bank CEO Mark Hardwick to retire at the end of 2026 and President Mike Stewart to become President and CEO

October 1, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Specimen Collection Cards Market Outlook 2023-2030: Industry Driven by Non-Invasive Genetic Testing and Personalized Medicine Trends
Press Release

Specimen Collection Cards Market Outlook 2023-2030: Industry Driven by Non-Invasive Genetic Testing and Personalized Medicine Trends

By News RoomJanuary 23, 20243 Mins Read
Specimen Collection Cards Market Outlook 2023-2030: Industry Driven by Non-Invasive Genetic Testing and Personalized Medicine Trends
Share
Facebook Twitter LinkedIn Pinterest Email

Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) — The “Specimen Collection Cards Market Size, Share & Trends Analysis, 2023-2030” report has been added to ResearchAndMarkets.com’s offering.

This market analysis report on the global specimen collection cards industry projects a substantial growth trajectory, fueled by the increasing focus on non-invasive diagnostic techniques, bespoke healthcare approaches, and the integration of these cards into personalized medicine initiatives. The forecast period of 2023-2030 is set to see the market size burgeon to an estimated USD 621.29 million, with a Compound Annual Growth Rate (CAGR) of 4.9%.

The demand for specimen collection cards is underpinned by the adoption of non-invasive medical protocols, which require less intrusive methods for sample collection, including blood, saliva, and other bodily fluids. As governments worldwide adopt favorable policies for newborn screening and bolster investments in healthcare research and development, this market segment is expected to benefit substantially.

Market Segmentation Insights

  • By application, the newborn screening field is anticipated to maintain its dominant market share, supported by proliferating government initiatives dedicated to infant health.
  • In terms of product types, the Whatman 903 product line is heralded for its extensive application across governmental and research endeavors, further consolidating its market prominence.
  • Advancements in materials, such as cotton & cellulose, are facilitating storage and stability of collected samples, subsequently enhancing the adoption rate of specimen collection cards formulated from these substances.

Distribution Channels and Regional Performance

The accessibility of specimen collection cards through traditional offline channels continues to account for a significant portion of the market, but the sector is witnessing a swift shift towards online platforms. Improvements in digital infrastructure are anticipated to catalyze the online segment’s growth over the coming years, thereby broadening global accessibility and convenience.

In terms of regional demand, North America is at the forefront, owing to the domicile of predominant market players and robust governmental backing. Hospitals and clinics, as principal end-users, further amplify the region’s market share, reinforcing North America’s leadership in the specimen collection cards sphere.

Impact of Technological Advancements and Personalized Healthcare

Technological strides in healthcare have paved the way for more targeted and individualized treatment approaches. Specimen collection cards are integral to this paradigm, simplifying the processes of genetic profiling and monitoring, and playing a crucial role in the burgeoning field of personalized medicine. Patients’ desire to engage proactively with their health regimens is further stimulating market expansion.

Key Market Players and Future Outlook

Industry stakeholders are strategically investing in research and development activities to refine specimen collection card technologies. Recent investments and funding in this sector underscore the market’s potential and the confidence in its continued growth trajectory. With a solid compound annual growth rate and a thriving ecosystem of support, the specimen collection cards industry is well-positioned for significant expansion through 2030.

Key Attributes

Report Attribute Details
No. of Pages 160
Forecast Period 2022-2030
Estimated Market Value (USD) in 2022 $424.02 million
Forecasted Market Value (USD) by 2030 $621.29 million
Compound Annual Growth Rate 4.9%
Regions Covered Global

Companies Mentioned

  • QIAGEN
  • PerkinElmer, Inc.
  • DBS System SA
  • Danaher Corporation
  • Eastern Business Forms, Inc.
  • Ahlstrom
  • ARCHIMED Life Science GmbH
  • GenTegra LLC
  • FortiusBio
  • CENTOGENE N.V.

For more information about this report visit https://www.researchandmarkets.com/r/8m6gxf

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

  • Global Specimen Collection Cards Market

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

The $200 Popcorn Popper That Keeps Selling Out

Challenged Athletes Foundation Receives Rings of Gold Award from U.S. Olympic & Paralympic Committee

CleanChoice Energy Closes Approximately $166M in Project Financing and Tax Equity for Two Solar Projects

Fabletics Launches Fabletics Reserve Credit Card, Expanding Value and Loyalty Perks to Its More than 2.7 Million Members

First Merchants Bank CEO Mark Hardwick to retire at the end of 2026 and President Mike Stewart to become President and CEO

Primech Holdings (Nasdaq: PMEC) Unveils Primech Vision, Integrating a Multi-Robot Facility Fleet and Workforce on One Platform; Live Customer Demonstrations Begin October 2026

Easy Environmental Solutions Ships First Commercial EasyFEN™ System to Kenya

The News Forum Presents Aftershock: The World After October 7, 2023

BloFin returns as TOKEN2049 Singapore title sponsor, opens its “NEXT WHALE ERA” chapter with 3rd anniversary afterparty

Editors Picks

Challenged Athletes Foundation Receives Rings of Gold Award from U.S. Olympic & Paralympic Committee

October 1, 2026

CleanChoice Energy Closes Approximately $166M in Project Financing and Tax Equity for Two Solar Projects

October 1, 2026

Fabletics Launches Fabletics Reserve Credit Card, Expanding Value and Loyalty Perks to Its More than 2.7 Million Members

October 1, 2026

First Merchants Bank CEO Mark Hardwick to retire at the end of 2026 and President Mike Stewart to become President and CEO

October 1, 2026

Latest News

Primech Holdings (Nasdaq: PMEC) Unveils Primech Vision, Integrating a Multi-Robot Facility Fleet and Workforce on One Platform; Live Customer Demonstrations Begin October 2026

October 1, 2026

Police seek answers in crash that killed 2 elders, hurt 2 others on BC First Nation

October 1, 2026

An AI agent tried to hack Canadian government website, researchers say

October 1, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version